SecBot SecBot
SECBOTREPLAY Home › Report › FMS

FMS · Fresenius SE & Co

Fresenius Medical Care AG · SC 13D/A filed Nov 13, 2026 at 15:26 ET

At the news

BEARISHIMPACT 5/10

SC 13D/A filed Nov 13, 2026 at 15:26 ET

Fresenius SE & Co. KGaA, the controlling shareholder of Fresenius Medical Care AG (FMS), sold 13,443,240 shares (approximately 5.0% of FMS's outstanding shares) at EUR 39.00 per share for gross proceeds of EUR 524 million, reducing its stake from 25.01% to 20.9%. The sale is part of Fresenius KGaA's portfolio optimization strategy and is subject to a 90-day lock-up on further share sales.

  • Fresenius KGaA sold 13,443,240 FMS shares at EUR 39.00 per share, gross proceeds EUR 524,286,360
  • Stake reduced from 25.01% (67,181,358 shares) to 20.9% (53,738,118 shares) of outstanding shares
  • Sale executed via accelerated bookbuild with BNP Paribas, BofA Securities, Deutsche Bank, and J.P. Morgan as joint bookrunners
  • Fresenius KGaA entered a 90-day lock-up on further share sales starting November 12, 2026

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access